-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
5 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$1.56 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$46,454
Athira Pharma, Inc. Insider Transactions
Athira Pharma, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Gengos Andrew
CFO and Chief Business Officer |
Sell | 1,272 @ $0.57 | $720 | 97,532 | 09/05/2024 | 09/05/2024 | |
|
Lenington Rachel
COO and CDO |
Sell | 2,525 @ $0.57 | $1,429 | 20,870 | 09/05/2024 | 09/05/2024 | |
|
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER |
Sell | 2,525 @ $0.57 | $1,429 | 92,684 | 09/05/2024 | 09/05/2024 | |
|
Worthington Mark
GENERAL COUNSEL |
Sell | 2,525 @ $0.57 | $1,429 | 51,927 | 09/05/2024 | 09/05/2024 | |
| Sell | 5,032 @ $0.57 | $2,848 | 159,365 | 09/05/2024 | 09/05/2024 | ||
|
Romano Kelly A
Director |
Buy | 27,400 @ $2.42 | $66,179 | 80,715 | 06/24/2024 | 06/25/2024 | |
|
Romano Kelly A
Director |
Buy | 15,000 @ $2.26 | $33,872 | 53,315 | 06/21/2024 | 06/25/2024 | |
|
Gengos Andrew
CFO AND CHIEF BUSINESS OFFICER |
Sell | 1,208 @ $2.91 | $3,515 | 83,804 | 01/05/2024 | 02/16/2024 | |
|
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER |
Sell | 2,412 @ $2.91 | $7,019 | 80,256 | 01/05/2024 | 02/16/2024 | |
| Sell | 4,820 @ $2.91 | $14,026 | 144,397 | 01/05/2024 | 01/08/2024 | ||
|
Worthington Mark
General Counsel |
Sell | 2,412 @ $2.91 | $7,019 | 34,452 | 01/05/2024 | 01/08/2024 | |
|
Lenington Rachel
COO |
Sell | 2,412 @ $2.91 | $7,019 | 13,395 | 01/05/2024 | 01/08/2024 | |
|
PERCEPTIVE ADVISORS LLC
Director, 10 percent owner: |
Buy | 163,954 @ $2.38 | $390,211 | 5,402,964 | 12/29/2023 | 12/29/2023 | |
|
PERCEPTIVE ADVISORS LLC
Director, 10 percent owner: |
Buy | 409,598 @ $2.44 | $999,419 | 5,239,010 | 12/28/2023 | 12/29/2023 | |
|
PERCEPTIVE ADVISORS LLC
Director, 10 percent owner: |
Buy | 32,134 @ $2.28 | $73,266 | 4,829,412 | 12/27/2023 | 12/29/2023 | |
|
Gengos Andrew
See Below |
Buy | 2,859 @ $3.40 | $9,721 | 68,293 | 06/07/2023 | 06/09/2023 | |
|
Gengos Andrew
See Below |
Buy | 11,719 @ $3.44 | $40,308 | 80,012 | 06/07/2023 | 06/09/2023 | |
|
Gengos Andrew
See Below |
Buy | 422 @ $3.36 | $1,417 | 65,434 | 06/07/2023 | 06/09/2023 | |
|
Gengos Andrew
See Below |
Buy | 15,000 @ $3.00 | $45,000 | 35,012 | 06/05/2023 | 06/06/2023 | |
|
Gengos Andrew
See Below |
Buy | 10,000 @ $3.00 | $29,997 | 45,012 | 06/05/2023 | 06/06/2023 |
Athira Pharma, Inc. Frequently Asked Questions
-
Who is on Athira Pharma, Inc.'s Insider Roster?
The list of insiders at Athira Pharma, Inc. includes PERCEPTIVE ADVISORS LLC, Lenington Rachel, Worthington Mark, Litton Mark James, CHURCH KEVIN, Gengos Andrew, Romano Kelly A.
-
How much insider selling is happening at Athira Pharma, Inc.?
Insiders have sold a total of 27,143 Athira Pharma, Inc. shares in the last 12 months for a total of 46,454 sold.
-
Which Athira Pharma, Inc. insiders have been selling company stock?
The following insiders have sold Athira Pharma, Inc. shares in the last 12 months: Lenington Rachel ($8,448), Worthington Mark ($8,448), Litton Mark James ($16,874), CHURCH KEVIN ($8,448), Gengos Andrew ($4,235),
-
How much insider buying is happening at Athira Pharma, Inc.?
Insiders have purchased a total of 648,086 Athira Pharma, Inc. shares in the last 12 months for a total of 1.56 M sold.
-
Which Athira Pharma, Inc. insiders have been buying company stock?
The following insiders have purchased Athira Pharma, Inc. shares in the last 12 months: PERCEPTIVE ADVISORS LLC ($1.46 M), Romano Kelly A ($100,051),